Niche nutraceuticals Specializes in first-in-class nutraceuticals that support apoptosis, offering a unique value proposition in veterinary oncology nutrition that can be leveraged to cross-sell to veterinary oncologists and pet owners seeking adjunctive therapies.

Veterinary oncology focus Established product line with Apocaps CX used by veterinarians and veterinary oncologists since 2010, indicating a proven market fit and an entry point for expanded sales to clinics, hospitals, and specialty practices.

USA manufacturing All products manufactured to high standards in USA facilities using 100% human-grade ingredients, which can be highlighted to premium channels and customers demanding rigorous quality and transparency.

Small team, outsized impact Team size under 10 with existing product familiarity and ongoing development, suggesting partner-focused, high-touch sales approaches and potential for channel partnerships to scale reach.

Growth through channels Current revenue under $1M and a tech stack that includes e-commerce, CRM, and marketing automation tools indicate opportunity to pursue partnerships with distributors, integrative health networks, and clinic-level ASP/BD collaborations to boost distribution and recurring sales.